{"id":81046,"date":"2026-06-10T21:22:17","date_gmt":"2026-06-10T21:22:17","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/81046\/"},"modified":"2026-06-10T21:22:17","modified_gmt":"2026-06-10T21:22:17","slug":"genentech-cuts-87-more-jobs-in-another-round-of-hq-layoffs","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/81046\/","title":{"rendered":"Genentech cuts 87 more jobs in another round of HQ layoffs"},"content":{"rendered":"<p>Genentech has executed another round of layoffs, eliminating 87 positions at its headquarters in South San Francisco.<\/p>\n<p>The dismissals, which were filed last week and are effective Sept. 15, were revealed in a California Worker Adjustment and Retraining Notification (WARN) report and &#8220;impacted multiple departments,&#8221; a company spokesperson said via email. The WARN Act requires employers to provide a 60-day notice on layoffs impacting 50 workers or more.<\/p>\n<p>It&#8217;s at least the fourth wave of job cuts from Genentech in the last 15 months, impacting more than 700 positions at the Roche subsidiary so far. The dismissals come after the company  in May, according to another WARN report.<\/p>\n<p>&#8220;The success and sustained growth of our business hinges on our ability to proactively identify innovation opportunities early and adapt to a changing external environment,&#8221; Roche said in a July 23 statement to Fierce. &#8220;This requires us to allocate and, at times, shift resources judiciously to enhance operational efficiency. We consistently evaluate all facets of our operations to ensure we remain well-positioned to meet patients\u2019 evolving needs today while continuing to deliver innovative new medicines in the future.&#8221;<\/p>\n<p>The spokesperson said that 2,000 positions are open at Roche and that the company anticipates its workforce will \u201cremain stable throughout 2025,&#8221; while &#8220;changes may occur in certain departments.&#8221;<\/p>\n<p>The layoffs also follow a 3% workforce reduction <a href=\"https:\/\/www.bizjournals.com\/sanfrancisco\/news\/2024\/04\/10\/genentech-roche-job-cuts-cancer.html\" rel=\"nofollow noopener\" target=\"_blank\">affecting<\/a> 436 Genentech employees in April of last year, with the company explaining that it was a strategic move designed to \u201cplace greater focus on the most-promising molecules in our portfolio.\u201d<\/p>\n<p>Then, in August of last year, Genentech revealed a major <a href=\"https:\/\/www.fiercebiotech.com\/biotech\/genentech-shut-down-cancer-immunology-department-amid-broader-downsizing-efforts\" target=\"_blank\" title=\"https:\/\/www.fiercebiotech.com\/biotech\/genentech-shut-down-cancer-immunology-department-amid-broader-downsizing-efforts\" rel=\"nofollow noopener\">restructuring initiative<\/a>\u00a0that included the closure of the company\u2019s cancer immunology research department. Later that month, the company announced even <a href=\"https:\/\/www.fiercebiotech.com\/biotech\/genentech-telegraphs-93-layoffs-ca-following-separate-job-cuts-reorganization\" target=\"_blank\" title=\"https:\/\/www.fiercebiotech.com\/biotech\/genentech-telegraphs-93-layoffs-ca-following-separate-job-cuts-reorganization\" rel=\"nofollow noopener\">more layoffs<\/a>,\u00a0this time impacting 93 employees in South San Francisco.<\/p>\n<p>In April, Roche\u00a0<a href=\"https:\/\/www.fiercepharma.com\/pharma\/bay-area-gilead-cuts-149-while-roche-eliminates-108-jobs\" rel=\"nofollow noopener\" target=\"_blank\">let go of 108 workers<\/a>\u00a0at its molecular systems division in Santa Clara, California. A few weeks later, the Swiss pharma announced a\u00a0<a href=\"https:\/\/www.fiercebiotech.com\/biotech\/roches-50b-us-investment-will-include-upcoming-boston-cvrm-site\" rel=\"nofollow noopener\" target=\"_blank\">$50 billion investment<\/a>\u00a0into its U.S. operations, including an\u00a0<a href=\"https:\/\/www.fiercebiotech.com\/medtech\/roche-spend-550m-building-indianapolis-hq-cgm-production-hub\" rel=\"nofollow noopener\" target=\"_blank\">Indianapolis diagnostics campus<\/a>,\u00a0<a href=\"https:\/\/www.fiercepharma.com\/manufacturing\/roche-gets-work-us-investment-plan-reveal-700m-obesity-drug-plant-north-carolina\" rel=\"nofollow noopener\" target=\"_blank\">a manufacturing plant in North Carolina<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.fiercebiotech.com\/biotech\/roches-50b-us-investment-will-include-upcoming-boston-cvrm-site\" rel=\"nofollow noopener\" target=\"_blank\">three R&amp;D sites<\/a>.<\/p>\n<p>Editor&#8217;s note: This story was updated at 11:50 a.m. ET to include comment from Roche and Genentech.<\/p>\n","protected":false},"excerpt":{"rendered":"Genentech has executed another round of layoffs, eliminating 87 positions at its headquarters in South San Francisco. The&hellip;\n","protected":false},"author":2,"featured_media":81047,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[1115,9273,9275,41939,1360,2984,134],"class_list":["post-81046","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-biotech","tag-biotech-layoffs","tag-fierce-biotech-homepage","tag-fierce-pharma-homepage","tag-genentech","tag-layoffs","tag-roche"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116727915902200970","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/81046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=81046"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/81046\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/81047"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=81046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=81046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=81046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}